Navigation Links
Decision Resources, Inc. Acquires Manhattan Research

Acquisition Expands Decision Resources, Inc.'s Portfolio to Include Global

Physician and Consumer Digital Market Research

WALTHAM, Mass. and NEW YORK, June 17 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, announced today that it acquired Manhattan Research, a leading provider of access to physician and consumer opinions on the global healthcare market. The acquisition of New York, NY-based Manhattan Research by Waltham, MA-based Decision Resources, Inc. will result in a significant expansion of Decision Resources, Inc.'s portfolio of premier market research and data businesses for the healthcare industry and give Decision Resources, Inc. a larger footprint in the consumer market research arena.

Manhattan Research's focus on physician and consumer use of information technology, including next generation digital media such as social networking, blogs, podcasts, and Web 2.0, sets the firm apart in the industry.

"We are excited to continue our growth as a Decision Resources, Inc. company," said Mark Bard, president and co-founder of Manhattan Research. "We look forward to continuing to expand our portfolio of client solutions with the economic and strategic resources now afforded to us as a member of the Decision Resources, Inc. family."

With more than half of all consumers using the Internet for health information and services, Manhattan Research services are in demand by marketing savvy life sciences organizations.

"Our innovative approach to strategic research and advisory services offers our clients a unique perspective on how physicians and consumers are gathering healthcare information through digital marketing vehicles," said Joe Farris, COO and co-founder of Manhattan Research. "Combining our insight with the industry expertise of Decision Resources, Inc. will provide our clients with a greater understanding of how to reach their target audience and craft their messages in line with evolving macro trends in the industry."

Acquisition Fulfills the Demand for Global Consumer and Physician Market Research

By sub-segmenting their research populations into therapeutic and specialist groups as well as showing utilization and motivation behind the usage behaviors, Manhattan Research expands Decision Resources, Inc.'s offering to include the type of consumer and physician market research that brand managers at biopharmaceutical companies urgently need.

"Manhattan Research is an important acquisition in Decision Resources, Inc.'s overall strategy to expand our portfolio of companies with firms that offer innovative, high-value market research solutions to the healthcare industry," said Peter Hoenigsberg, CEO of Decision Resources, Inc. "The digital age has brought a wealth of healthcare information to physicians and consumers, and Manhattan Research is at the forefront of measuring and analyzing the impact of that information and turning it into actionable lessons-learned for life sciences organizations. This area of market research will continue to be one of the most dynamic for years to come."

Manhattan Research will remain headquartered in New York, NY.

About Manhattan Research

Manhattan Research is a healthcare market research and advisory services firm, bringing clarity to the market forces, trends, and impacts of physician and consumer use of information technology, including next generation digital media such as social networking, blogs, podcasts, and Web 2.0. Through analysis of Manhattan Research's trended, proprietary data sets analysts provide global pharmaceutical companies with the insight necessary to strategically plan and market existing and future therapies. Manhattan Research was advised by AdMedia Partners, an independent merger and acquisition advisory firm based in New York City that provides M&A advice to digital and traditional media, marketing and information businesses.

About Decision Resources

Decision Resources, Inc. is a world leader in healthcare market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. The company provides insight on the managed care industry (, the medical device industry (, the biopharmaceutical industry (, the hospital-based drug and imaging industry ( and U.S. formulary data (

All company, brand, or product names contained in this document may be

trademarks or registered trademarks of their respective holders.

For more information, contact:

Elizabeth Marshall

Decision Resources, Inc.


SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. QLT announces positive Health Canada decision on Aczone(R)
2. Kendle to Host Conference Call and Webcast to Discuss DecisionLine Acquisition and Provide Update on Second Quarter Progress
3. Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation
4. MammaPrint(R) Breast Cancer Test Provides Valuable Insight for Personalized Treatment Decisions
5. Better business decisions with real-time data
6. Decision Biomarkers Launches System for Faster, Easier Quantification of Protein Biomarkers
7. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
8. U.S. District Court Decision About Eisais Legal Action Over Aricept ODT(R) ANDA Filing
9. Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry
10. Scientists Using Social Media to Inform Lab Purchasing Decisions
11. NPS Pharmaceuticals to Report Third Quarter 2007 Financial Results and Nycomed Decision on GATTEX(TM) Partnership on November 1, 2007
Post Your Comments:
(Date:6/23/2016)... SILVER SPRING, Md. , June 23, 2016 ... evidence collected from the crime scene to track the criminal ... sick, and the U.S. Food and Drug Administration (FDA) uses ... Sound far-fetched? It,s not. ... whole genome sequencing to support investigations of foodborne illnesses. Put ...
(Date:6/23/2016)... Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator (YI) ... of the Class of 2016 were selected from a pool of 128 applicants ... the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... today announced the launch of the Supplyframe Design Lab . Located in ... to explore the future of how hardware projects are designed, built and brought ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology:
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:5/9/2016)... , UAE, May 9, 2016 ... when it comes to expanding freedom for high net ... Even in today,s globally connected world, there is ... conferencing system could ever duplicate sealing your deal with ... obtaining second passports by taking advantage of citizenship via ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):